Unity Biotechnology, Inc. (UBX)
NASDAQ: UBX · Real-Time Price · USD
0.7714
-0.0136 (-1.73%)
At close: Jun 27, 2025, 4:00 PM
0.7999
+0.0285 (3.69%)
After-hours: Jun 27, 2025, 7:25 PM EDT

Unity Biotechnology Statistics

Total Valuation

UBX has a market cap or net worth of $13.28 million. The enterprise value is $18.95 million.

Market Cap 13.28M
Enterprise Value 18.95M

Important Dates

The next estimated earnings date is Tuesday, August 5, 2025, after market close.

Earnings Date Aug 5, 2025
Ex-Dividend Date n/a

Share Statistics

UBX has 17.21 million shares outstanding. The number of shares has increased by 9.47% in one year.

Current Share Class 17.21M
Shares Outstanding 17.21M
Shares Change (YoY) +9.47%
Shares Change (QoQ) +0.08%
Owned by Insiders (%) 1.90%
Owned by Institutions (%) 11.36%
Float 15.88M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.95

Current Ratio 1.95
Quick Ratio 1.87
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -231.27% and return on invested capital (ROIC) is -47.83%.

Return on Equity (ROE) -231.27%
Return on Assets (ROA) -38.89%
Return on Invested Capital (ROIC) -47.83%
Return on Capital Employed (ROCE) -130.44%
Revenue Per Employee n/a
Profits Per Employee -$1.72M
Employee Count 16
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -44.10% in the last 52 weeks. The beta is 1.06, so UBX's price volatility has been similar to the market average.

Beta (5Y) 1.06
52-Week Price Change -44.10%
50-Day Moving Average 0.84
200-Day Moving Average 1.31
Relative Strength Index (RSI) 46.57
Average Volume (20 Days) 523,424

Short Selling Information

The latest short interest is 572,503, so 3.33% of the outstanding shares have been sold short.

Short Interest 572,503
Short Previous Month 873,204
Short % of Shares Out 3.33%
Short % of Float 3.61%
Short Ratio (days to cover) 1.09

Income Statement

Revenue n/a
Gross Profit -12.06M
Operating Income -27.76M
Pretax Income -27.86M
Net Income -27.50M
EBITDA -26.94M
EBIT -27.76M
Earnings Per Share (EPS) -$1.63
Full Income Statement

Balance Sheet

The company has $16.93 million in cash and $22.61 million in debt, giving a net cash position of -$5.67 million or -$0.33 per share.

Cash & Cash Equivalents 16.93M
Total Debt 22.61M
Net Cash -5.67M
Net Cash Per Share -$0.33
Equity (Book Value) -205,000
Book Value Per Share -0.01
Working Capital 8.58M
Full Balance Sheet

Cash Flow

Operating Cash Flow -22.04M
Capital Expenditures n/a
Free Cash Flow -22.04M
FCF Per Share -$1.28
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

UBX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -9.47%
Shareholder Yield -9.47%
Earnings Yield -207.13%
FCF Yield -165.99%

Analyst Forecast

The average price target for UBX is $4.67, which is 505.39% higher than the current price. The consensus rating is "Strong Buy".

Price Target $4.67
Price Target Difference 505.39%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on October 20, 2022. It was a reverse split with a ratio of 0.1:1.

Last Split Date Oct 20, 2022
Split Type Reverse
Split Ratio 0.1:1

Scores

Altman Z-Score n/a
Piotroski F-Score 1